Mirae Asset Global Investments Portfolio holdings
AUM
$28.7B
1-Year Return
20.96%
This Quarter Return
+15.82%
1 Year Return
+20.96%
3 Year Return
+114.88%
5 Year Return
+202.83%
10 Year Return
+496.23%
AUM
$28.7B
AUM Growth
+$4.18B
(+17%)
Cap. Flow
-$12.2B
Cap. Flow
% of AUM
-42.5%
Top 10 Holdings %
Top 10 Hldgs %
36.41%
Holding
1,665
New
77
Increased
1,004
Reduced
446
Closed
86
Top Buys
| 1 |
SPDR Portfolio S&P 500 ETF
SPLG
|
$69.1M |
| 2 |
iShares S&P 100 ETF
OEF
|
$58.9M |
| 3 |
iShares MBS ETF
MBB
|
$58.1M |
| 4 |
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
|
$58.1M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
$34.2M |
Top Sells
| 1 |
Pinduoduo
PDD
|
$4.12B |
| 2 |
MakeMyTrip
MMYT
|
$2.34B |
| 3 |
Trip.com Group
TCOM
|
$752M |
| 4 |
Yum China
YUMC
|
$508M |
| 5 |
Alibaba
BABA
|
$457M |
Sector Composition
| 1 | Technology | 34.56% |
| 2 | Communication Services | 9.63% |
| 3 | Consumer Discretionary | 9.36% |
| 4 | Healthcare | 6.11% |
| 5 | Financials | 5.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GMRE
1501
Global Medical REIT
GMRE
$505M
| $9.12K | ﹤0.01% |
1,316
-398
| -23% | -$2.76K |
|
1502
MaxCyte
MXCT
$145M
| $8.95K | ﹤0.01% |
4,107
+793
| +24% | +$1.73K |
|
1503
Zillow
ZG
$19.6B
| $8.9K | ﹤0.01% |
130
-5
| -4% | -$342 |
|
1504
Tevogen Bio Holdings
TVGN
$173M
| $8.88K | ﹤0.01% |
7,104
+1,247
| +21% | +$1.56K |
|
1505
SPDR Blackstone Senior Loan ETF
SRLN
$6.97B
| $8.65K | ﹤0.01% |
208
-156
| -43% | -$6.49K |
|
|
OLP
1506
One Liberty Properties
OLP
$509M
| $8.54K | ﹤0.01% |
358
-104
| -23% | -$2.48K |
|
1507
TransUnion
TRU
$17.3B
| $8.45K | ﹤0.01% |
+96
| New | +$8.45K |
|
1508
Neurogene
NGNE
$280M
| $8.24K | ﹤0.01% |
551
+60
| +12% | +$897 |
|
1509
OmniAb
OABI
$230M
| $8.22K | ﹤0.01% |
4,726
+1,107
| +31% | +$1.93K |
|
1510
Vertex
VERX
$3.84B
| $8.16K | ﹤0.01% |
231
-7,856
| -97% | -$278K |
|
|
CBL
1511
CBL Properties
CBL
$975M
| $8.13K | ﹤0.01% |
320
-12
| -4% | -$305 |
|
|
API
1512
Agora
API
$299M
| $8.05K | ﹤0.01% |
2,112
-324
| -13% | -$1.23K |
|
1513
Chunghwa Telecom
CHT
$34.1B
| $8.02K | ﹤0.01% |
+172
| New | +$8.02K |
|
1514
Inhibrx
INBX
$402M
| $7.98K | ﹤0.01% |
559
+71
| +15% | +$1.01K |
|
1515
Payoneer
PAYO
$2.41B
| $7.95K | ﹤0.01% |
1,160
-7,320
| -86% | -$50.1K |
|
1516
Y-mAbs Therapeutics
YMAB
$389M
| $7.89K | ﹤0.01% |
1,750
+245
| +16% | +$1.11K |
|
1517
United Microelectronic
UMC
$17.3B
| $7.89K | ﹤0.01% |
+1,031
| New | +$7.89K |
|
1518
AC Immune
ACIU
$216M
| $7.88K | ﹤0.01% |
3,879
+570
| +17% | +$1.16K |
|
1519
Codexis
CDXS
$218M
| $7.81K | ﹤0.01% |
3,200
+428
| +15% | +$1.04K |
|
1520
scPharmaceuticals
SCPH
$300M
| $7.77K | ﹤0.01% |
2,039
+365
| +22% | +$1.39K |
|
1521
Esperion Therapeutics
ESPR
$510M
| $7.54K | ﹤0.01% |
7,656
+1,260
| +20% | +$1.24K |
|
1522
Design Therapeutics
DSGN
$348M
| $7.39K | ﹤0.01% |
2,193
+298
| +16% | +$1K |
|
|
CRGX
1523
DELISTED
CARGO Therapeutics
CRGX
| $7.34K | ﹤0.01% |
1,781
+241
| +16% | +$993 |
|
1524
Larimar Therapeutics
LRMR
$331M
| $7.15K | ﹤0.01% |
2,473
+388
| +19% | +$1.12K |
|
1525
Editas Medicine
EDIT
$227M
| $7.12K | ﹤0.01% |
3,234
+512
| +19% | +$1.13K |
|